16 September 2026
At the meeting of 18 August 2026 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| adrenal insufficiency | 58/2026 | 59/2026 |
| Guillain-Barre syndrome | 60/2026 | 61/2026 |
| immersion pulmonary oedema | 62/2026 | 63/2026 |
| cerebral meningioma | 64/2026 | 65/2026 |
| chilblains | 66/2026 | 67/2026 |
These SOPs revoke the SOPs previously determined for these conditions.
The above SOPs take effect from 5 October 2026.
Completed Investigations
The above determinations conclude the previously advertised investigations into: